Skip to contentV
Vycor Medical Inc
V
VYCOVycor Medical Inc Q2 2022 · 10-Q
Revenue$327.92K$327.92K−33.3% vs Q2 2021 Net Income-$99.01K-$99.01KN/M vs Q2 2021 EPS Diluted$0.00$0.00— vs Q2 2021 Gross Profit$300,038−33.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
Operating Cash Flowderived-$28,136N/M Margins · derivedGross margin91.5%−0.5 pt vs Q2 2021
Operating margin-22.7%−27.5 pt vs Q2 2021
Net margin-30.2%−28.3 pt vs Q2 2021
ended Jun 30, 2022 · filed Aug 15, 2022 · 46 d after period end